with Geron may have cost you quite a bit of money (Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies).
Don't let that happen again with Prana. JMHO, of course.
Absolutely right, pivalde. And I would like to second what wcamp said below--patience and an eye on the science are what a biotech investor needs.
OMG please explain how a stock trading well under a $1 could open one morning for $100/share? The only way that's possible is if there is 100/1 reverse split. You pumpers are seriously deluded
sammy long time no see . I see no one has injected brains into your head in the year since this identity has been here. I am sorry they didnt.
Read it. Loved it. Bought more PRAN because of it.
Sentiment: Strong Buy